Hikma Pharmaceuticals PLC banner

Hikma Pharmaceuticals PLC
LSE:HIK

Watchlist Manager
Hikma Pharmaceuticals PLC Logo
Hikma Pharmaceuticals PLC
LSE:HIK
Watchlist
Price: 1 240 GBX 2.56% Market Closed
Market Cap: £2.8B

Profitability Summary

Hikma Pharmaceuticals PLC's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Hikma Pharmaceuticals PLC

Margins Comparison
Hikma Pharmaceuticals PLC Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
UK
Hikma Pharmaceuticals PLC
LSE:HIK
2.8B GBP
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
930.7B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
581.6B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
256.9B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
233.7B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
222.2B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
286.1B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.1B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
118.9B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Hikma Pharmaceuticals PLC Competitors

Country Company Market Cap ROE ROA ROCE ROIC
UK
Hikma Pharmaceuticals PLC
LSE:HIK
2.8B GBP
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
930.7B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
581.6B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
256.9B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
233.7B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
222.2B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
286.1B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.1B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
118.9B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Hikma Pharmaceuticals PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett